Loading…

P776: A PHASE 2, OPEN‐LABEL, ASCENDING DOSE STUDY OF KER‐050 FOR THE TREATMENT OF ANEMIA IN PATIENTS WITH VERY LOW, LOW, OR INTERMEDIATE RISK MYELODYSPLASTIC SYNDROMES

Saved in:

Bibliographic Details
Published in:	HemaSphere 2022-06, Vol.6, p.671-672
Main Authors:	Tan, S., Arbelaez, A., Chee, L., Fong, C. Y., Hiwase, D., Kannourakis, G., Kwan, J., Liang, J., Puliyayil, A., Rose, H., Ross, D., Teh, T.‐C., Westerman, D., Wight, J., Feng, W., Lachey, J., McGinty, A., Natarajan, H., Rovaldi, C., Cooper, S.
Format:	Article
Language:	English
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!